Advion Sells Service Business and Focuses on Instruments

The sale gives Advion new funds to support its instrument business, which includes chip-based electrospray ionization technology. Upcoming products include a compact single quadrupole MS designed for synthetic organic chemists.

Ithaca, NY 10/26/11; Research Triangle Park, NC 10/26/11—Advion, a provider of LC and MS products, has announced the sale of its Biosciences business to Quintiles Transnational for an undisclosed amount. Advion Biosciences provides bioanalytical services. Advion CEO and President David Patteson and Dr. Jack Henion, company chief scientific officer, chairman and cofounder, will remain with Advion in their current roles.

< | >